Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
The OncLive Insider app is live!
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Practical Considerations in Breast Cancer
EP. 1: Overview of HER2-Targeted Therapies in Breast Cancer
January 22nd 2014
EP. 2: Treating Low-Risk HER2-Positive Breast Cancer
January 22nd 2014
EP. 3: Frontline Pertuzumab for Metastatic Breast Cancer
January 22nd 2014
EP. 4: PIK3CA Mutations in HER2-Positive Breast Cancer
January 22nd 2014
EP. 5: T-DM1 in HER2-Positive Metastatic Breast Cancer
January 22nd 2014
EP. 6: Recommendations for Optimal HER2 Testing in Breast Cancer
January 22nd 2014
EP. 7: Role of Lapatinib in HER2-Positive Breast Cancer
January 22nd 2014
EP. 8: Novel Drug Development in Breast Cancer
January 22nd 2014
EP. 9: Phase III Clinical Trials in HER2-Positive Breast Cancer
January 22nd 2014
EP. 10: Case Study: HER2-Positive Oligometastatic Breast Cancer
January 22nd 2014
EP. 11: Upfront Treatment of HR-Positive MBC
January 22nd 2014
EP. 12: Next Steps for Everolimus in Metastatic Breast Cancer
January 22nd 2014
EP. 13: CDK4/6 Inhibitors in Metastatic Breast Cancer
January 22nd 2014
EP. 14: Chemotherapeutics in Metastatic Breast Cancer
January 22nd 2014
EP. 15: Preventing Skeletal-Related Events in Breast Cancer
January 22nd 2014
EP. 16: Conclusion: Future Direction of Breast Cancer Treatment
January 22nd 2014
x